ValuEngine Downgrades CVS Health (CVS) to Sell

Adjust Comment Print

Hunter Associates Investment Management LLC boosted its holdings in CVS Health by 2.6% in the second quarter.

The institutional investor held 99,477 shares of the medical and nursing services company at the end of 2017Q4, valued at $7.21M, up from 54,525 at the end of the previous reported quarter. Reaves W H & Company Inc who had been investing in South Jersey Ind for a number of months, seems to be bullish on the $2.59 billion market cap company. In last trading session, the stock received negative focus on shares from Traders. The share price has already crossed its 20 days moving average, floating at a distance of 7.17% and sits 5.94% higher versus its 50 days moving average. Eastern Savings Bank holds 1.08% in CVS Health Corporation (NYSE:CVS) or 222,903 shares. CVS underperformed the S&P500 by 34.36%.

Burgundy Asset Management Ltd decreased its stake in Copart Inc. The firm owned 17,883 shares of the pharmacy operator's stock after selling 4,184 shares during the period. The Endurance Wealth Management Inc holds 79,727 shares with $5.78M value, down from 116,428 last quarter. The stock decreased 2.13% or $3.16 during the last trading session, reaching $144.93. About 295,289 shares traded.

The beta factor is 1.04.Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. It has outperformed by 49.50% the S&P500. Therefore 57% are positive. Since November 3, 2017 according to StockzIntelligence Inc CVS Health has 30 analyst reports. Cowen & Co maintained the stock with "Buy" rating in Tuesday, September 19 report.

Columbia Partners L L C Investment Management lessened its stake in CVS Health (NYSE:CVS) by 19.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm has "Buy" rating given on Wednesday, November 9 by Mizuho. Finally, Morgan Stanley raised CVS Health from an "equal weight" rating to an "overweight" rating and set a $88.00 price objective on the stock in a research note on Friday, January 5th. Mark Sheptoff Fincl Planning Ltd has invested 1.67% of its portfolio in CVS Health Corporation (NYSE:CVS). The stock of CVS Health Corporation (NYSE:CVS) earned "Hold" rating by Jefferies on Monday, December 12. SunTrust has "Buy" rating and $10.0 target. Cim Investment Mangement owns 14,671 shares for 0.36% of their portfolio. Finally, Veritas Asset Management LLP boosted its position in CVS Health by 2.8% during the third quarter.

Investors sentiment decreased to 0.72 in Q4 2017. That's change of 0.16, from 2017Q3's 0.88. 134 funds opened positions while 380 raised stakes. Funds hold 815.59 million shares thus 1.76% more from 2017Q3's 801.45 million shares. Intrust Bank & Trust Na holds 10,122 shares or 0.22% of its portfolio. It dived, as 15 investors sold CUZ shares while 70 reduced holdings. St James Co Limited Company holds 6.59% or 786,377 shares. Bp Plc holds 118,000 shares. The stock of CVS Health Corporation (NYSE:CVS) earned "Neutral" rating by Citigroup on Tuesday, February 13. Carret Asset Mngmt Lc invested 1.08% in CVS Health Corporation (NYSE:CVS). I have formerly spent over 3 years as a trader in U.S. Stock Market and is now semi-stepped down. Arvest National Bank & Trust Trust Division owns 189,380 shares. Utd Capital Advisers Limited Liability invested in 0.13% or 226,514 shares. 11,645 are held by Exane Derivatives.

Yum China (YUMC) Short Interest Update
The company reported $0.53 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.05, reports. Brands (NYSE:YUM) to post earnings per share (EPS) of $0.68 for the current fiscal quarter, Zacks reports.

BofA/Merrill Resumed shares of CVS Health Corporation (NYSE:CVS) to a Buy rating in a report posted on Tuesday, February 27th, 2018.

Currently Analysts have a mean recommendation of 2.00 on the shares. Atria Investments Ltd Liability Corporation reported 0.14% stake. Maryland-based Horan Cap has invested 1.62% in CVS Health Corporation (NYSE:CVS). Profund Advsr Ltd Liability reported 33,801 shares.

Since February 16, 2018, it had 0 insider buys, and 1 sale for $1.42 million activity. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company's stock. Therefore 48% are positive. Cousins Properties had 15 analyst reports since November 24, 2015 according to SRatingsIntel. The company was maintained on Wednesday, August 16 by Jefferies. The ex-dividend date of this dividend is Friday, April 20th. The firm has "Outperform" rating given on Tuesday, May 16 by Robert W. Baird. The firm has "Sell" rating given on Thursday, September 29 by Stifel Nicolaus. This Rhode Island-based company has more than 900 walk-in medical clinics-CVS/MinuteClinic and now possesses a customer satisfaction rate of 95%. On Thursday, August 25 the stock rating was downgraded by Buckingham Research to "Underperform". The stock of Copart, Inc. The rating was downgraded by Atlantic Securities to "Neutral" on Monday, February 6. The hedge fund held 529,150 shares of the consumer services company at the end of 2017Q4, valued at $27.13M, down from 536,700 at the end of the previous reported quarter. As per Friday, October 27, the company rating was maintained by Robert W. Baird. Leerink Swann maintained the stock with "Buy" rating in Tuesday, November 21 report.

Analysts await Copart, Inc. (NASDAQ:EXTR) to report earnings on May, 8 after the close. EXTR's profit will be $14.98 million for 20.85 P/E if the $0.13 EPS becomes a reality. For every buyer, there is a seller, and each transaction contributes to the count of total volume. $2,242 worth of GenMark Diagnostics, Inc. (NASDAQ:CPRT) was sold by Blunt Matt.

As regular trading ended, DPW Holdings, Inc. Hemenway Tru Company Llc reported 155,150 shares.